Hideki Maeda

20PUBLICATIONS
17CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsMolecular targetsPharmacology and pharmaceutical sciences not elsewhere classifiedEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 17, 2026
Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination.

|Jul 29, 2026
Post-Marketing Requirements for Anticancer Drugs Approved in Japan, 2001-2024: A Cross-Sectional Analysis.

|Jun 25, 2026
Identifying Factors Associated with the Acquisition of Multiple Indications for Anticancer Drugs.

|Jun 08, 2026
Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development.

|Dec 03, 2025
Interactions Between Pharmaceutical Companies and Patient Advocacy Groups in Japan: A Qualitative and Quantitative Interview Study.

Ayaka Kikuchi, Asuka Hara, Akihiko Ozaki

|Nov 12, 2025
Surrogate Endpoints in Pivotal Clinical Trials for Drug Approval in Japan Compared to the United States.

Yuko Yamamoto, Harumi Kosaka, Hanami Nojiri

Pageof 4

Frequent Collaborators

2 joint publications

Hiroe Kitagaki

2 joint publications

Kentaro Takeda

2 joint publications

Keiko Yamamoto

1 joint publications

Toshihiro Misumi